Annual CFO
-$39.89 M
-$4.43 M-12.51%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual cash flow from operations is -$39.89 million, with the most recent change of -$4.43 million (-12.51%) on December 31, 2023.
- During the last 3 years, VIRX annual CFO has fallen by -$23.84 million (-148.49%).
- VIRX annual CFO is now -148.49% below its all-time high of -$16.05 million, reached on December 31, 2020.
Performance
VIRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$7.09 M
+$2.73 M+27.82%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly cash flow from operations is -$7.09 million, with the most recent change of +$2.73 million (+27.82%) on September 30, 2024.
- Over the past year, VIRX quarterly CFO has increased by +$2.93 million (+29.26%).
- VIRX quarterly CFO is now -378.05% below its all-time high of $2.55 million, reached on March 31, 2021.
Performance
VIRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$34.80 M
+$3.44 M+9.00%
September 30, 2024
Summary
- As of February 8, 2025, VIRX TTM cash flow from operations is -$34.80 million, with the most recent change of +$3.44 million (+9.00%) on September 30, 2024.
- Over the past year, VIRX TTM CFO has increased by +$5.10 million (+12.77%).
- VIRX TTM CFO is now -851.23% below its all-time high of -$3.66 million, reached on March 31, 2020.
Performance
VIRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VIRX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.5% | +29.3% | +12.8% |
| 3 y3 years | -148.5% | +29.3% | +12.8% |
| 5 y5 years | -148.5% | +29.3% | +12.8% |
VIRX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.6% | at low | at high | +37.6% | -84.6% | +12.8% |
| 5 y | 5-year | -148.5% | at low | -378.1% | +37.6% | -851.2% | +12.8% |
| alltime | all time | -148.5% | at low | -378.1% | +37.6% | -851.2% | +12.8% |
Viracta Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.09 M(-27.8%) | -$34.80 M(-9.0%) |
| Jun 2024 | - | -$9.83 M(+25.2%) | -$38.24 M(+5.0%) |
| Mar 2024 | - | -$7.85 M(-21.7%) | -$36.40 M(-8.8%) |
| Dec 2023 | -$39.89 M(+12.5%) | -$10.03 M(-4.8%) | -$39.89 M(+5.6%) |
| Sep 2023 | - | -$10.54 M(+31.9%) | -$37.77 M(+9.8%) |
| Jun 2023 | - | -$7.99 M(-29.5%) | -$34.39 M(-2.9%) |
| Mar 2023 | - | -$11.34 M(+43.5%) | -$35.43 M(-0.1%) |
| Dec 2022 | -$35.46 M | -$7.90 M(+10.4%) | -$35.46 M(+2.0%) |
| Sep 2022 | - | -$7.16 M(-20.8%) | -$34.77 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$9.03 M(-20.5%) | -$35.21 M(+7.5%) |
| Mar 2022 | - | -$11.36 M(+57.6%) | -$32.77 M(+73.8%) |
| Dec 2021 | -$18.85 M(+17.4%) | -$7.21 M(-5.1%) | -$18.85 M(+16.5%) |
| Sep 2021 | - | -$7.60 M(+15.2%) | -$16.18 M(+26.0%) |
| Jun 2021 | - | -$6.59 M(-358.4%) | -$12.84 M(+30.4%) |
| Mar 2021 | - | $2.55 M(-156.2%) | -$9.85 M(-38.7%) |
| Dec 2020 | -$16.05 M | -$4.54 M(+6.7%) | -$16.05 M(+39.4%) |
| Sep 2020 | - | -$4.25 M(+18.2%) | -$11.51 M(+58.6%) |
| Jun 2020 | - | -$3.60 M(-1.6%) | -$7.26 M(+98.4%) |
| Mar 2020 | - | -$3.66 M | -$3.66 M |
FAQ
- What is Viracta Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Viracta Therapeutics?
- What is Viracta Therapeutics annual CFO year-on-year change?
- What is Viracta Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly CFO year-on-year change?
- What is Viracta Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Viracta Therapeutics?
- What is Viracta Therapeutics TTM CFO year-on-year change?
What is Viracta Therapeutics annual cash flow from operations?
The current annual CFO of VIRX is -$39.89 M
What is the all time high annual CFO for Viracta Therapeutics?
Viracta Therapeutics all-time high annual cash flow from operations is -$16.05 M
What is Viracta Therapeutics annual CFO year-on-year change?
Over the past year, VIRX annual cash flow from operations has changed by -$4.43 M (-12.51%)
What is Viracta Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VIRX is -$7.09 M
What is the all time high quarterly CFO for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly cash flow from operations is $2.55 M
What is Viracta Therapeutics quarterly CFO year-on-year change?
Over the past year, VIRX quarterly cash flow from operations has changed by +$2.93 M (+29.26%)
What is Viracta Therapeutics TTM cash flow from operations?
The current TTM CFO of VIRX is -$34.80 M
What is the all time high TTM CFO for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM cash flow from operations is -$3.66 M
What is Viracta Therapeutics TTM CFO year-on-year change?
Over the past year, VIRX TTM cash flow from operations has changed by +$5.10 M (+12.77%)